126 related articles for article (PubMed ID: 2853763)
1. Kinetic-dynamic relationships and antihypertensive mechanisms of ketanserin in essential hypertension.
Donnelly R; Elliott HL; Meredith PA; Reid JL
J Hypertens Suppl; 1988 Dec; 6(4):S643-5. PubMed ID: 2853763
[TBL] [Abstract][Full Text] [Related]
2. Ketanserin concentration-effect relationships in individual hypertensive patients.
Donnelly R; Elliott HL; Meredith PA; Hughes DM; Reid JL
Br J Clin Pharmacol; 1988 Jul; 26(1):61-4. PubMed ID: 3203061
[TBL] [Abstract][Full Text] [Related]
3. Concentration-effect relationships and antihypertensive mechanisms: ketanserin in the treatment of essential hypertension.
Elliott HL; Meredith PA
J Hypertens Suppl; 1990 Sep; 8(4):S69-71. PubMed ID: 2258787
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics.
Donnelly R; Elliott HL; Meredith PA; Reid JL
Br J Clin Pharmacol; 1987 Nov; 24(5):599-606. PubMed ID: 3325090
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
Persson B; Gradin K; Pettersson A; Hedner T
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive mechanism of ketanserin in postoperative hypertension after cardiopulmonary bypass.
Anger C; Carter JA; Prys-Roberts C
Anesth Analg; 1988 Feb; 67(2):99-106. PubMed ID: 3277483
[TBL] [Abstract][Full Text] [Related]
7. The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.
Blauw GJ; van Brummelen P; Doorenbos CJ; van der Velde EA; van Zwieten PA
Clin Pharmacol Ther; 1991 Apr; 49(4):377-84. PubMed ID: 1849810
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat.
Pettersson A; Gradin K; Hedner T; Persson B
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):394-7. PubMed ID: 2993926
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of ketanserin in hypertension and vasospastic disease.
Wenting GJ; Brouwer RM; vd Meiracker AJ; Man in't Veld AJ; Schalekamp MA
Acta Cardiol; 1987; 42(5):339-54. PubMed ID: 2827406
[TBL] [Abstract][Full Text] [Related]
10. Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
Cameron HA; Waller PC; Ramsay LE
Br J Clin Pharmacol; 1987 Dec; 24(6):705-11. PubMed ID: 2894215
[TBL] [Abstract][Full Text] [Related]
11. Effects of ketanserin on peripheral vascular pressor mechanisms in essential hypertension.
Elliott HL; Donnelly R; Reid JL
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S62-6. PubMed ID: 2459518
[TBL] [Abstract][Full Text] [Related]
12. Oral dosing with ketanserin to control high blood pressure in the elderly.
van Oene JC
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():111-4. PubMed ID: 2285639
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of ketanserin: studies on cardiovascular reactivity in essential and diabetes-associated hypertension.
Waser M; Ziegler WH; Beretta-Piccoli C
J Hypertens; 1988 Jun; 6(6):471-9. PubMed ID: 3411125
[TBL] [Abstract][Full Text] [Related]
14. Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension.
Egan B; Conlon ME; Campbell R; Schork N; Zwiefler A; Julius S
Am J Hypertens; 1988 Jul; 1(3 Pt 3):324S-330S. PubMed ID: 3415805
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure during a combination of ketanserin and hydrochlorothiazide.
Ferrara LA; Fasano ML; Soro S; Farinaro E; Celentano E; Mancini M
Int J Clin Pharmacol Res; 1987; 7(6):463-8. PubMed ID: 3440636
[TBL] [Abstract][Full Text] [Related]
16. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
[TBL] [Abstract][Full Text] [Related]
17. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
Vanhoutte P; Amery A; Birkenhäger W; Breckenridge A; Bühler F; Distler A; Dormandy J; Doyle A; Frohlich E; Hansson L
Hypertension; 1988 Feb; 11(2):111-33. PubMed ID: 3277910
[TBL] [Abstract][Full Text] [Related]
18. Concentration-effect relationships and individual responses to doxazosin in essential hypertension.
Donnelly R; Elliott HL; Meredith PA; Reid JL
Br J Clin Pharmacol; 1989 Nov; 28(5):517-26. PubMed ID: 2531605
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of ketanserin after a single dose and at steady-state in hypertensive subjects.
Waller PC; Tucker GT; Ramsay LE
Eur J Clin Pharmacol; 1987; 33(4):423-6. PubMed ID: 3443148
[TBL] [Abstract][Full Text] [Related]
20. Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertension.
Ito K; Omae T; Ikeda M; Iimura O; Yoshinaga K; Ishii M; Kaneko Y; Mizuno Y; Masuyama Y; Takeda T
Drugs; 1988; 36 Suppl 1():18-24. PubMed ID: 3071459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
